Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes
- 1 July 2014
- journal article
- Published by Spandidos Publications in Biomedical Reports
- Vol. 2 (5), 633-636
- https://doi.org/10.3892/br.2014.309
Abstract
The aim of the present study was to reveal the metabolic disorders most commonly associated with nonalcoholic fatty liver disease (NAFLD). Triglyceride (TG), high‑density lipoprotein cholesterol (HDL), low‑density lipoprotein cholesterol (LDL), blood glucose (BG) and hemoglobin A1c (HbA1c) were analyzed. NAFLD was diagnosed using abdominal ultrasound (US), and TG, HDL, LDL, BG and HbA1c were immediately collected on the same day and subjected to multivariate regression analysis. Stepwise analysis was performed to select the variables that were closely associated with NAFLD. The patients who were positive for the hepatitis B antigen and hepatitis C antibody were excluded from the study. Additionally, the patients who were prescribed prednisolone or methotrexate were excluded from the study as these agents may cause NAFLD or liver toxicity. The study included 168 and 125 patients with and without NAFLD, respectively. TG, BG and HbA1c were strongly correlated with NAFLD. Among these parameters, TG was the strongest predictor of NAFLD (χ2=9.89, P=0.0017). TG was the parameter that was most strongly associated with NAFLD. In conclusion, elevated TG was a marker of NAFLD.Keywords
This publication has 26 references indexed in Scilit:
- Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patientsThe Esophagus, 2013
- Hepatic function and the cardiometabolic syndromeDiabetes, Metabolic Syndrome and Obesity, 2013
- Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methodsAlimentary Pharmacology & Therapeutics, 2012
- Body mass index is the most useful predictive factor for the onset of nonalcoholic fatty liver disease: a community-based retrospective longitudinal cohort studyThe Esophagus, 2012
- Incidence of Liver Toxicity in Inflammatory Bowel Disease Patients Treated with Methotrexate: A Meta-Analysis of Clinical TrialsInflammatory Bowel Diseases, 2012
- Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severityAnnals of Medicine, 2010
- A Pilot Study Using Simvastatin in the Treatment of Nonalcoholic SteatohepatitisJournal of Clinical Gastroenterology, 2009
- Exposure to a high total dosage of glucocorticoids produces non‐alcoholic steatohepatitsPathology International, 2007
- Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver studyJournal of Hepatology, 2005
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitisJournal of Hepatology, 1999